嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06998 嘉和生物-B

交易中 12-19 13:05:29

1.690

-0.070

-3.98%

最高1.720	最低1.680	成交量3.85万
今开1.720	昨收1.760	日振幅2.27%
总市值8.79亿	流通市值8.79亿	总股本5.20亿
成交额6.55万	换手率0.01%	流通股本5.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06998","market":"HK","secType":"STK","nameCN":"嘉和生物-B","latestPrice":1.69,"timestamp":1734584474182,"preClose":1.76,"halted":0,"volume":38500,"delay":0,"floatShares":520000000,"shares":520000000,"eps":-1.4289559,"marketStatus":"交易中","marketStatusCode":2,"change":-0.07,"latestTime":"12-19 13:05:29","open":1.72,"high":1.72,"low":1.68,"amount":65490,"amplitude":0.022727,"askPrice":1.77,"askSize":8000,"bidPrice":1.69,"bidSize":27500,"shortable":0,"etf":0,"ttmEps":-1.113693045442528,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734595800000},"adr":0,"listingDate":1602000000000,"adjPreClose":1.76,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.491801,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06998","defaultTab":"news","newsList":[{"id":"2492882959","title":"嘉和生物-B盘中异动 下午盘股价大涨5.29%报1.790港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492882959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492882959?lang=zh_cn&edition=full","pubTime":"2024-12-17 13:57","pubTimestamp":1734415025,"startTime":"0","endTime":"0","summary":"2024年12月17日下午盘13时57分，嘉和生物-B股票出现波动，股价快速拉升5.29%。截至发稿，该股报1.790港元/股，成交量13.7万股，换手率0.03%，振幅7.65%。资金方面，该股资金流入14.3245万港元，流出7.56万港元。嘉和生物-B股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，乐普生物-B、北海康成-B、和铂医药-B涨幅较大，振幅较大的相关个股有圣诺医药-B、乐普生物-B、晶泰控股-P，振幅分别为19.88%、16.98%、15.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217135705ab7e4556&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217135705ab7e4556&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"2491638866","title":"嘉和生物-B盘中异动 临近午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491638866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491638866?lang=zh_cn&edition=full","pubTime":"2024-12-16 11:30","pubTimestamp":1734319851,"startTime":"0","endTime":"0","summary":"2024年12月16日临近午盘11时30分，嘉和生物-B股票出现异动，股价大幅上涨5.00%。截至发稿，该股报1.680港元/股，成交量2.85万股，换手率0.01%，振幅5.00%。嘉和生物-B股票所在的生物技术行业中，整体跌幅为1.04%。其相关个股中，华康生物医学、晶泰控股-P、嘉和生物-B涨幅较大，振幅较大的相关个股有创胜集团-B、思路迪医药股份、华康生物医学，振幅分别为18.03%、14.56%、13.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216113051ab7b3dea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216113051ab7b3dea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1574","BK1583"],"gpt_icon":0},{"id":"2490954098","title":"因受限制股份单位获归属 嘉和生物-B(06998)发行7250股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490954098","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490954098?lang=zh_cn&edition=full","pubTime":"2024-12-10 18:28","pubTimestamp":1733826525,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉和生物-B(06998)发布公告，于2024年12月10日，该公司因选定参与者根据于2021年6月3日采纳的2021年受限制股份单位计划归属受限制股份单位而发行7250股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"2490932087","title":"嘉和生物-B盘中异动 早盘快速上涨6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490932087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490932087?lang=zh_cn&edition=full","pubTime":"2024-12-09 10:24","pubTimestamp":1733711071,"startTime":"0","endTime":"0","summary":"2024年12月09日早盘10时24分，嘉和生物-B股票出现波动，股价大幅上涨6.90%。截至发稿，该股报1.550港元/股，成交量2.45万股，换手率0.00%，振幅6.90%。嘉和生物-B股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，永泰生物-B、云康集团、药明康德涨幅较大，振幅较大的相关个股有永泰生物-B、圣诺医药-B、晶泰科技，振幅分别为18.33%、13.33%、10.64%。嘉和生物-B公司简介：嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209102431a1df2305&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209102431a1df2305&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","06998"],"gpt_icon":0},{"id":"2488640988","title":"嘉和生物-B盘中异动 大幅拉升8.51%报1.530港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488640988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488640988?lang=zh_cn&edition=full","pubTime":"2024-12-02 15:43","pubTimestamp":1733125420,"startTime":"0","endTime":"0","summary":"2024年12月02日临近收盘15时43分，嘉和生物-B股票出现波动，股价急速上涨8.51%。截至发稿，该股报1.530港元/股，成交量1.35万股，换手率0.00%，振幅8.51%。资金方面，该股资金流入1.688万港元，流出2820港元。嘉和生物-B股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，云顶新耀-B、思路迪医药股份、康诺亚-B涨幅较大，振幅较大的相关个股有北海康成-B、云顶新耀-B、友芝友生物-B，振幅分别为23.02%、17.49%、11.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202154341971b20d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202154341971b20d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2486863706","title":"嘉和生物(06998.HK)委任独立财务顾问  就CFO留任计划等提意见","url":"https://stock-news.laohu8.com/highlight/detail?id=2486863706","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486863706?lang=zh_cn&edition=full","pubTime":"2024-11-27 09:23","pubTimestamp":1732670580,"startTime":"0","endTime":"0","summary":"嘉和生物-B(06998.HK) 公布，新百利融资已获委任为独立财务顾问，以就执行董事兼首席财务官翁承毅的留任计划及就此的投票行动向上市规则独立董事委员会及独立股东；以及建议合并、清洗豁免及股东人员留任计划和就此的投票行动，向收购守则独立董事委员会及独立股东提供意见。(js/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210316101711838_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210316101711838_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1399768/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1161","06998","BK1574"],"gpt_icon":0},{"id":"2486861544","title":"嘉和生物-B：新百利成独立财务顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=2486861544","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486861544?lang=zh_cn&edition=full","pubTime":"2024-11-27 08:12","pubTimestamp":1732666365,"startTime":"0","endTime":"0","summary":"【嘉和生物-B发布重要公告！】嘉和生物-B宣布，新百利融资有限公司已获委任为独立财务顾问，其依据证券及期货条例获发牌进行第1类受规管活动。该公司将为独立股东及上市规则独立董事委员会，就翁先生的留任计划及相关投票行动提供意见。同时，也会为收购守则独立董事委员会及独立股东，就建议合并、清洗豁免及股东人员留任计划以及相关投票行动提供意见。并且，委任新百利融资有限公司为独立财务顾问已获收购守则独立董事委员会根据收购守则第2.1条批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127102451abe207b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127102451abe207b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2486300231","title":"嘉和生物-B：新百利融资获委任为独立财务顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=2486300231","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486300231?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:07","pubTimestamp":1732633622,"startTime":"0","endTime":"0","summary":"格隆汇11月26日丨嘉和生物-B公告，董事会欣然宣布，新百利融资有限公司已获委任为独立财务顾问，以就翁的留任计划及就此的投票行动向上市规则独立董事委员会及独立股东；及建议合并、清洗豁免及股东人员留任计划以及就此的投票行动向收购守则独立董事委员会及独立股东提供意见。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126231131a25758b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126231131a25758b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08439","BK1161","06998","BK1156","BK1574","BK1583"],"gpt_icon":0},{"id":"2486001298","title":"嘉和生物-B(06998)委任新百利融资为独立财务顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=2486001298","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486001298?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:49","pubTimestamp":1732632558,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉和生物-B(06998)发布公告，新百利融资有限公司(一间根据证券及期货条例获发牌进行第 1类(证券交易)及第6类(就机构融资提供意见)受规管活动的法团)已获委任为独立财务顾问，以就翁先生的留任计划及就此的投票行动向上市规则独立董事委员会及独立股东;及建议合并、清洗豁免及股东人员留任计划(包括翁先生的留任计划)以及就此的投票行动向收购守则独立董事委员会及独立股东提供意见。委任新百利融资有限公司为独立财务顾问已获收购守则独立董事委员会根据收购守则第2.1条批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216304.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1156","BK1583","BK1574","BK1161","08439","06998"],"gpt_icon":0},{"id":"2486747467","title":"嘉和生物-B盘中异动 快速跳水6.04%报1.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486747467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486747467?lang=zh_cn&edition=full","pubTime":"2024-11-25 10:32","pubTimestamp":1732501945,"startTime":"0","endTime":"0","summary":"2024年11月25日早盘10时32分，嘉和生物-B股票出现波动，股价急速跳水6.04%。截至发稿，该股报1.400港元/股，成交量9500股，换手率0.00%，振幅4.70%。资金方面，该股资金流入1.016万港元，流出3600港元。嘉和生物-B股票所在的生物技术行业中，整体涨幅为1.08%。嘉和生物-B公司简介：嘉和生物药业(开曼)控股有限公司是一家主要从事生物制药产品研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125103225a2532f30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125103225a2532f30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1574","BK1583"],"gpt_icon":0},{"id":"1135202110","title":"异动解读 | 嘉和生物-B与亿腾医药合并 股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135202110","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135202110?lang=zh_cn&edition=full","pubTime":"2024-11-22 11:20","pubTimestamp":1732245645,"startTime":"0","endTime":"0","summary":"嘉和生物-B(06998)盘中大涨6.43%,引发市场关注。此前,嘉和生物与亿腾医药宣布了一项合并协议,这被认为是导致该股大涨的主要原因。\n\n根据协议内容,亿腾医药将收购港交所上市公司嘉和生物,双方实现整合。这意味着亿腾医药借此机会实现上市,而嘉和生物则可获得亿腾在商业化运营方面的实力支持。\n\n业内人士认为,合并后的新公司将进一步提升研发和商业化能力。嘉和生物拥有丰富的15大在研管线和重磅产品储备,而亿腾医药则拥有遍布全国的销售网络和稳健的现金流。通过优势互补,新公司研发和商业化发展均将获得提升,市场竞争力将大大增强。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 嘉和生物-B与亿腾医药合并 股价大涨6.43%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06998"],"gpt_icon":0},{"id":"2485340988","title":"嘉和生物-B盘中异动 早盘股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485340988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485340988?lang=zh_cn&edition=full","pubTime":"2024-11-22 11:18","pubTimestamp":1732245539,"startTime":"0","endTime":"0","summary":"2024年11月22日早盘11时18分，嘉和生物-B股票出现波动，股价大幅上涨6.43%。截至发稿，该股报1.490港元/股，成交量3.5万股，换手率0.01%，振幅6.43%。嘉和生物-B股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，来凯医药-B、嘉和生物-B、宜明昂科-B涨幅较大，振幅较大的相关个股有华领医药-B、来凯医药-B、晶泰科技，振幅分别为16.67%、13.83%、10.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122111859a24cd0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122111859a24cd0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2485740956","title":"嘉和生物－Ｂ(06998)股价上升6.429%，现价港币$1.49","url":"https://stock-news.laohu8.com/highlight/detail?id=2485740956","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485740956?lang=zh_cn&edition=full","pubTime":"2024-11-22 11:18","pubTimestamp":1732245480,"startTime":"0","endTime":"0","summary":"[上升股]嘉和生物－Ｂ(06998) 股价在上午11:18比前收市价上升6.429%，现股价为港币$1.49。至目前为止，今日最高价为$1.49，而最低价为$1.4。总成交量为3.5万股，总成交金额为港币$4.982万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411221094/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06998","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2485447205","title":"亿腾医药转型升级，收购嘉和生物实现跨越发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2485447205","media":"极目新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485447205?lang=zh_cn&edition=full","pubTime":"2024-11-22 09:43","pubTimestamp":1732239808,"startTime":"0","endTime":"0","summary":"近日，嘉和生物与亿腾医药联合宣布了一项具有深远影响的合并协议，标志着亿腾在上市的道路上迈出了重要一步。　　亿腾医药经过多年的转型升级，已逐步发展成为一家具备研发、生产、供应链和销售综合能力的医药企业。而嘉和生物，则是一家在研发领域具有较强实力的港交所主板上市公司，拥有多个具有潜力的药物管线。然而，近...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OkeGqNwa_EbJgchTKQOrRTaxIdnRhzf4pHiy9Rh49eA4wAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OkeGqNwa_EbJgchTKQOrRTaxIdnRhzf4pHiy9Rh49eA4wAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241122A02BBR00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241122A02BBR00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["06998","BK1574","BK1515","09939","BK1583","BK1161"],"gpt_icon":0},{"id":"2485476969","title":"嘉和生物-B因受限制股份单位获归属发行7250股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485476969","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485476969?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:37","pubTimestamp":1732235860,"startTime":"0","endTime":"0","summary":"嘉和生物-B（06998）发布公告，于2024年11月21日，该公司因选定参与者根据于2021年6月3日采纳的2021年受限制股份单位计划归属受限制股份单位而发行7250股股份。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-22/doc-incwwvuu0799057.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-22/doc-incwwvuu0799057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"2485846580","title":"因受限制股份单位获归属 嘉和生物-B(06998)发行7250股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485846580","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485846580?lang=zh_cn&edition=full","pubTime":"2024-11-21 18:34","pubTimestamp":1732185285,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉和生物-B(06998)发布公告，于2024年11月21日，该公司因选定参与者根据于2021年6月3日采纳的2021年受限制股份单位计划归属受限制股份单位而发行7250股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","06998","BK1161","BK1574"],"gpt_icon":0},{"id":"2484096402","title":"嘉和生物-B盘中异动 下午盘股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484096402","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484096402?lang=zh_cn&edition=full","pubTime":"2024-11-19 14:23","pubTimestamp":1731997436,"startTime":"0","endTime":"0","summary":"2024年11月19日下午盘14时23分，嘉和生物-B股票出现异动，股价快速下挫5.59%。截至发稿，该股报1.520港元/股，成交量27.55万股，换手率0.05%，振幅5.59%。嘉和生物-B股票所在的生物技术行业中，整体涨幅为0.00%。嘉和生物-B公司简介：嘉和生物药业(开曼)控股有限公司是一家主要从事生物制药产品研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119142356a244e30a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119142356a244e30a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1583","BK1574"],"gpt_icon":0},{"id":"2483736766","title":"嘉和生物-B盘中异动 股价大跌5.45%报1.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483736766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483736766?lang=zh_cn&edition=full","pubTime":"2024-11-15 09:52","pubTimestamp":1731635551,"startTime":"0","endTime":"0","summary":"2024年11月15日早盘09时52分，嘉和生物-B股票出现异动，股价急速下跌5.45%。截至发稿，该股报1.560港元/股，成交量10万股，换手率0.02%，振幅4.85%。资金方面，该股资金流入1750港元，流出15.984万港元。嘉和生物-B股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，北海康成-B、迈博药业-B、百奥赛图-B涨幅较大，振幅较大的相关个股有北海康成-B、晶泰科技、荃信生物-B，振幅分别为25.64%、16.52%、8.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111509523198e42c88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111509523198e42c88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2483015190","title":"嘉和生物-B盘中异动 早盘股价大跌5.56%报1.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483015190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483015190?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:22","pubTimestamp":1731464555,"startTime":"0","endTime":"0","summary":"2024年11月13日早盘10时22分，嘉和生物-B股票出现异动，股价大幅跳水5.56%。截至发稿，该股报1.700港元/股，成交量8.85万股，换手率0.02%，振幅3.33%。资金方面，该股资金流入0港元，流出8.4905万港元。嘉和生物-B股票所在的生物技术行业中，整体跌幅为1.98%。嘉和生物-B公司简介：嘉和生物药业(开曼)控股有限公司是一家主要从事生物制药产品研发的中国公司。该公司主要于中国市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111310223698e423f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111310223698e423f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","06998"],"gpt_icon":0},{"id":"2479216625","title":"亿腾上市新机遇：并购嘉和生物，开启全球化发展之路","url":"https://stock-news.laohu8.com/highlight/detail?id=2479216625","media":"华山网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479216625?lang=zh_cn&edition=full","pubTime":"2024-10-30 10:56","pubTimestamp":1730256960,"startTime":"0","endTime":"0","summary":"近日，亿腾医药通过反向收购18A上市公司嘉和生物，不仅打破了港股18A并购市场的沉寂，更为亿腾上市开辟了一条全新的路径。嘉和生物在TCE双抗和多特异性抗体领域的领先地位，将为亿腾医药带来新的增长点。同时，站在亿腾上市的新起点上，亿腾嘉和将更加积极地拥抱全球化趋势，大力拓展国际市场，为中国生物科技行业的繁荣与发展贡献更为显著的力量，展现上市企业的国际影响力与担当。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-10-30/doc-incuiaqz7950639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","162414","BK1161","06998","BK1583"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1069},{"period":"1month","weight":0.0932},{"period":"3month","weight":0.0667},{"period":"6month","weight":0.4915},{"period":"1year","weight":0.7255},{"period":"ytd","weight":0.479}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"嘉和生物药业（开曼）控股有限公司是一家主要从事生物制药产品研发的中国公司。该公司专注于开发及商业化肿瘤学及自身免疫性疾病。该公司的主要的药物包括lerociclib（GB491）、coprelotamab（GB221）、geptanolimab（GB226）、GB492、GB242以及GB223。该公司主要于中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.084821},{"month":2,"riseRate":0.25,"avgChangeRate":-0.024439},{"month":3,"riseRate":0.5,"avgChangeRate":0.022442},{"month":4,"riseRate":0.25,"avgChangeRate":-0.147203},{"month":5,"riseRate":0.5,"avgChangeRate":-0.020922},{"month":6,"riseRate":0.75,"avgChangeRate":0.079153},{"month":7,"riseRate":0.25,"avgChangeRate":-0.144734},{"month":8,"riseRate":0.25,"avgChangeRate":-0.022403},{"month":9,"riseRate":0.5,"avgChangeRate":-0.083889},{"month":10,"riseRate":0.5,"avgChangeRate":-0.003872},{"month":11,"riseRate":0.2,"avgChangeRate":-0.044191},{"month":12,"riseRate":0.8,"avgChangeRate":0.084586}],"exchange":"SEHK","name":"嘉和生物-B","nameEN":"GENOR-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供嘉和生物-B(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"嘉和生物-B,06998,嘉和生物-B股票,嘉和生物-B股票老虎,嘉和生物-B股票老虎国际,嘉和生物-B行情,嘉和生物-B股票行情,嘉和生物-B股价,嘉和生物-B股市,嘉和生物-B股票价格,嘉和生物-B股票交易,嘉和生物-B股票购买,嘉和生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供嘉和生物-B(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}